Table 2.
Biochemical characteristics of male and female primary biliary cirrhosis patients at hepatocellular carcinoma diagnosis
| Variable | Total | Men | Women | P value1 |
| (n = 52) | (n = 16) | (n = 36) | ||
| Alanine transaminase (U/L) | 43.04 ± 42.28 | 64.25 ± 55.48 | 33.61 ± 31.45 | 0.012 |
| Aspartate aminotransferase (U/L) | 77.83 ± 56.24 | 111.38 ± 72.47 | 62.92 ± 40.19 | 0.005 |
| Alkaline phosphatase (U/L) | 229.29 ± 190.44 | 308.81 ± 209.37 | 193.94 ± 172.87 | 0.015 |
| γ-glutamyl transpeptidase (U/L) | 156.90 ± 179.05 | 253.13 ± 220.54 | 114.14 ± 140.55 | 0.010 |
| Albumin (g/L) | 28.42 ± 5.67 | 28.06 ± 5.64 | 28.58 ± 5.75 | 0.720 |
| Total bilirubin (μmol/dL) | 61.19 ± 102.13 | 74.14 ± 64.25 | 55.43 ± 115.41 | 0.071 |
| α-fetoprotein elevating, n (%) | 34 (65.38) | 9 (56.25) | 25 (69.44) | 0.356 |
| Prothrombin time (s) | 13.49 ± 2.20 | 12.79 ± 1.91 | 13.8 ± 2.28 | 0.159 |
| International standardization ratio | 1.15 ± 0.23 | 1.13 ± 0.14 | 1.17 ± 0.26 | 0.410 |
| White blood cells (109/L) | 4.29 ± 2.35 | 5.13 ± 2.32 | 3.92 ± 2.30 | 0.073 |
| Red blood cells (1012/L) | 3.31 ± 0.66 | 3.56 ± 0.76 | 3.19 ± 0.60 | 0.096 |
| Platelets (109/L) | 76.57 ± 40.50 | 85.20 ± 48.26 | 72.74 ± 36.64 | 0.506 |
1
Men compared with women. Data expressed as mean ± SD or n (%) of patients.